12/2/2025 4:16:31 PM Skinny labels ≠ safe harbor: evolving liability for second medical use patents in Germany By Andreas Obermeier Anna Wolters-Höhne Phoebe Greybanks Recent German court decisions have fundamentally shifted the risk landscape for generic and biosimilar companies facing second medical...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-12-02-16-13-49-524-692f103daf6a1ce029cea04b.png)